Results 201 to 210 of about 170,400 (293)

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

USP43 promotes cerebral ischemia-reperfusion injury via activation of TAK1. [PDF]

Cell Biosci
Dong Y, Hu S, Zhang R, Zhang T, Feng Y, Sun W, Zhang P, Chen J, Zhao W.   +8 more
europepmc   +1 more source

A contemporary simple risk score for prediction of severe acute kidney injury after heart transplantation

ESC Heart Failure, Volume 12, Issue 2, Page 1166-1175, April 2025.
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu, Weihua Qiao, Yixuan Wang, Ying Zhou, Yin Xu, Shijie Wang, Tian Xia, Guohua Wang, Si Chen, Jiawei Shi, Nianguo Dong   +10 more
wiley   +1 more source

Correction to "Failure to Protect Against Myocardial Ischemia-Reperfusion Injury With Sevoflurane Postcondioning in Old Rats In Vivo". [PDF]

Acta Anaesthesiol Scand
europepmc   +1 more source

MFSD2A: a molecular nexus linking blood-brain barrier, lipid metabolism, and ischemia-reperfusion injury. [PDF]

Cell Mol Biol Lett
Li C, Ibrahim MM, Fang C.
europepmc   +1 more source

Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury

, 2004
Alok S. Pachori, Luis G. Melo, Melanie L. Hart, Nicolas Noiseux, Lunan Zhang, Fulvio Morello, Scott D. Solomon, Gregory L. Stahl, Richard E. Pratt, Victor J. Dzau   +9 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Serine Glycine Restriction Aggravates Hepatic Ischemia-reperfusion Injury. [PDF]

Transplantation
Yang M, Wang J, Li C, Yang Z, Dong W, Zhang C, Jin J.   +6 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Spinal cord-protective effect of resorcimoline for ischemia-reperfusion injury in a rabbit model. [PDF]

JTCVS Open
Kawahara Y, Kawashima T, Yoshimura K, Mori K, Nagashima R, Umeno T, Nishida H, Sato H, Higuchi A, Tokumaru O, Miyamoto S.   +10 more
europepmc   +1 more source